These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 12928640

  • 1. Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation.
    Kanemitsu S, Nishikawa M, Onoda K, Shimono T, Shimpo H, Yazaki A, Tanaka K, Shiku H, Yada I.
    J Thorac Cardiovasc Surg; 2003 Aug; 126(2):428-35. PubMed ID: 12928640
    [Abstract] [Full Text] [Related]

  • 2. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.
    Straub A, Wendel HP, Azevedo R, Ziemer G.
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):617-21. PubMed ID: 15784360
    [Abstract] [Full Text] [Related]

  • 3. The state of platelets preserved in extracorporeal circulation with a glycoprotein IIb/IIIa inhibitor.
    Kondo N, Wakayama F, Suzuki Y, Fukui K, Takaya S, Fukuda I.
    Thromb Res; 2004 Apr; 113(5):303-10. PubMed ID: 15183042
    [Abstract] [Full Text] [Related]

  • 4. Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia.
    Peter K, Straub A, Kohler B, Volkmann M, Schwarz M, Kübler W, Bode C.
    Am J Cardiol; 1999 Sep 01; 84(5):519-24. PubMed ID: 10482148
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Platelet anaesthesia during extracorporeal circulation: differential effects of GP IIb/IIIa blockers on platelet activation marker P-selectin expression at hypothermia.
    Straub A, Schiebold D, Wendel HP, Azevedo R, Dietz K, Ziemer G.
    Thromb Res; 2008 Sep 01; 122(3):383-9. PubMed ID: 18304613
    [Abstract] [Full Text] [Related]

  • 8. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
    Gawaz M, Ruf A, Pogatsa-Murray G, Dickfeld T, Rüdiger S, Taubitz W, Fischer J, Müller I, Meier D, Patscheke H, Schömig A.
    Thromb Haemost; 2000 Jun 01; 83(6):915-22. PubMed ID: 10896249
    [Abstract] [Full Text] [Related]

  • 9. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion.
    Rossi F, Rossi E, Pareti FI, Colli S, Tremoli E, Gallo L.
    Haematologica; 2001 Feb 01; 86(2):192-8. PubMed ID: 11224490
    [Abstract] [Full Text] [Related]

  • 10. Platelet preservation with a glycoprotein IIb/IIIa inhibitor in a porcine cardiopulmonary bypass model.
    Kondo N, Suzuki Y, Wakayama F, Tamai Y, Ji K, Fukui K, Fukuda I.
    Ann Thorac Surg; 2005 Jul 01; 80(1):251-7. PubMed ID: 15975376
    [Abstract] [Full Text] [Related]

  • 11. Effects of extracorporeal circulation and heparin on the phenotype of platelet surface antigens following heart surgery.
    Wahba A, Rothe G, Lodes H, Barlage S, Schmitz G, Birnbaum DE.
    Thromb Res; 2000 Mar 15; 97(6):379-86. PubMed ID: 10704646
    [Abstract] [Full Text] [Related]

  • 12. Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation: implications for restenosis during percutaneous coronary intervention.
    Day JR, Malik IS, Weerasinghe A, Poullis M, Nadra I, Haskard DO, Taylor KM, Landis RC.
    Heart; 2004 Jul 15; 90(7):794-9. PubMed ID: 15201252
    [Abstract] [Full Text] [Related]

  • 13. Ability of anti-glycoprotein IIb/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions.
    Goto S, Tamura N, Ishida H.
    J Am Coll Cardiol; 2004 Jul 21; 44(2):316-23. PubMed ID: 15261925
    [Abstract] [Full Text] [Related]

  • 14. Disappearance of glycoprotein Ib from the platelet surface in pericardial blood during cardiopulmonary bypass.
    Maquelin KN, Berckmans RJ, Nieuwland R, Schaap MC, ten Have K, Eijsman L, Sturk A.
    J Thorac Cardiovasc Surg; 1998 May 21; 115(5):1160-5. PubMed ID: 9605086
    [Abstract] [Full Text] [Related]

  • 15. Ability of different glycoprotein IIb-IIIa ligands to support platelet aggregation induced by activating antibody CRC54.
    Naimushin YA, Mazurov AV.
    Biochemistry (Mosc); 2005 Jul 21; 70(7):782-9. PubMed ID: 16097942
    [Abstract] [Full Text] [Related]

  • 16. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
    Chung A, Wildhirt SM, Wang S, Koshal A, Radomski MW.
    J Thorac Cardiovasc Surg; 2005 Apr 21; 129(4):782-90. PubMed ID: 15821644
    [Abstract] [Full Text] [Related]

  • 17. P2Y12 receptor blockade augments glycoprotein IIb-IIIa antagonist inhibition of platelet activation, aggregation, and procoagulant activity.
    Berny-Lang MA, Jakubowski JA, Sugidachi A, Barnard MR, Michelson AD, Frelinger AL.
    J Am Heart Assoc; 2013 May 15; 2(3):e000026. PubMed ID: 23676293
    [Abstract] [Full Text] [Related]

  • 18. In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blocking platelet function in plasma of patients with heparin-induced thrombocytopenia.
    Mak KH, Kottke-Marchant K, Brooks LM, Topol EJ.
    Thromb Haemost; 1998 Dec 15; 80(6):989-93. PubMed ID: 9869172
    [Abstract] [Full Text] [Related]

  • 19. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
    Gawaz M, Ruf A, Neumann FJ, Pogátsa-Murray G, Dickfeld T, Zohlnhöfer D, Schömig A.
    Thromb Haemost; 1998 Dec 15; 80(6):994-1001. PubMed ID: 9869173
    [Abstract] [Full Text] [Related]

  • 20. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
    Perez-Pujol S, Tonda R, Lozano M, Fuste B, Lopez-Vilchez I, Galan AM, Li J, Goodrich R, Escolar G.
    Transfusion; 2005 Jun 15; 45(6):911-9. PubMed ID: 15934989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.